Overview
Members of our Board of Directors are appointed for a maximum term of four years - reappointment of Directors is done on a rotation basis.
The Board of Directors defines the strategic business guidelines and directions of the Company, and supervises their implementation. Subject to the powers expressly attributed to the Shareholders’ General Meeting, and within the scope of the company’s corporate purpose, the Board of Directors’ powers cover all issues relating to the proper management of the company and through its decisions the Board determines all matters falling within its authority.
Composition of the Board of Directors
The Board of Directors, appointed by the shareholders, is composed of 17 members, two of whom are employee representatives.
Frédéric Oudéa
Chairman of the Board of Directors
Term expires 2027
Paul Hudson
Chief Executive Officer
Term expires 2026
Christophe Babule
Director
Term expires 2026
Clotilde Delbos
Independent director
Term expires 2027
Rachel Duan
Independent director
Term expires 2028
Carole Ferrand
Independent director
Term expires 2025
Lise Kingo
Independent director
Term expires 2028
Patrick Kron
Independent director
Term expires 2026
Wolfgang Laux
Director representing employees (designated by the European Works Council)
Term expires 2025
Barbara Lavernos
Director
Term expires 2025
Fabienne Lecorvaisier
Independent director
Term expires 2025
Anne-Françoise Nesmes
Independent director
Term expires 2027
Gilles Schnepp
Independent director
Term expires 2026
John Sundy
Independent director
Term expires 2027
Ceng-Yann Tran
Director representing employees
Term expires 2025
Emile Voest
Independent director
Term expires 2025
Antoine Yver
Independent director
Term expires 2025
Board Diversity
Each year, the Board of Directors conducts a review to ensure that there is an appropriate balance in its composition. In particular, the Board seeks to ensure gender balance and a broad diversity of backgrounds and countries of origin, international experience, reflecting Sanofi’s status as a diversified global business.
Women represent 47% of members. 8 Directors are non-French. Above all, the Board seeks directors who show independence of mind and who are competent, dedicated and committed.
Independence of Board Members
Under the terms of the AFEP-MEDEF corporate governance code of listed corporations, a Director is independent when he or she has no relation of any kind whatsoever with the company, its group or its management that may interfere with his or her freedom of judgement.
80% of members are independent (according to French Law, Directors representing employees are excluded when calculating the proportion of independent Directors).
Summary table
Director | Age | Nationality | First Appointed | Term expires | Seniority | AC | AGC | CC | SC | SciC | EC |
---|---|---|---|---|---|---|---|---|---|---|---|
Frédéric Oudéa | 61 | French | May 2023 | General Meeting 2027 | 1 | X | C | X | |||
Paul Hudson | 57 | British | September 2019 | General Meeting 2026 | 5 | X | C | ||||
Christophe Babule | 59 | French | February 2019 | General Meeting 2026 | 5 | X | |||||
Clotilde Delbos | 57 | French | April 2024 | General Meeting 2027 | <1 | X | X | ||||
Rachel Duan | 54 | Chinese | April 2020 | General Meeting 2028 | 4 | X | |||||
Carole Ferrand | 54 | French | May 2022 | General Meeting 2025 | 2 | C | |||||
Lise Kingo | 63 | Danish | April 2020 | General Meeting 2028 | 4 | X | |||||
Patrick Kron | 71 | French | May 2014 | General Meeting 2026 | 10 | X | C | X | |||
Wolfgang Laux | 56 | German | April 2021 | General Meeting 2025 | 3 | X | |||||
Barbara Lavernos | 56 | French | April 2021 | General Meeting 2025 | 3 | X | X | ||||
Fabienne Lecorvaisier | 62 | French | May 2013 | General Meeting 2025 | 11 | X | |||||
Anne-Françoise Nesmes | 53 | British, French | April 2024 | General Meeting 2027 | <1 | X | |||||
Gilles Schnepp | 65 | French | May 2020 | General Meeting 2026 | 4 | C | X | ||||
John Sundy | 63 | American | April 2024 | General Meeting 2027 | <1 | X | |||||
Ceng-Yann Tran | 58 | French | May 2021 | General Meeting 2025 | 3 | ||||||
Emile Voest | 65 | Dutch | May 2022 | General Meeting 2025 | 2 | X | |||||
Antoine Yver | 66 | French, American, Swiss | May 2022 | General Meeting 2025 | 2 | X | C |
AC: Audit Committee
AGC: Appointments, Governance and CSR Committee
CC: Compensation Committee
SC: Strategy Committee
SciC: Scientific Committee
C: Chairman/Chairwoman